Peter J Little Selected Research

galactosaminoglycan

1/2018

Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J Little Research Topics

Disease

69	Atherosclerosis 09/2022 - 01/2002
24	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 05/2002
13	Inflammation (Inflammations) 09/2022 - 01/2007
10	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2011
8	Neoplasms (Cancer) 01/2021 - 12/2016
6	Thrombosis (Thrombus) 12/2021 - 08/2018
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2003
6	Hyperglycemia 01/2021 - 05/2002
6	Vascular Diseases (Vascular Disease) 01/2020 - 12/2010
4	Insulin Resistance 12/2018 - 05/2006
3	Myocardial Infarction 09/2022 - 01/2016
3	Fibrosis (Cirrhosis) 12/2021 - 01/2011
3	Obesity 01/2021 - 06/2020
3	Wounds and Injuries (Trauma) 01/2018 - 05/2002
3	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2016
3	Neointima 05/2014 - 05/2003
3	Hypertension (High Blood Pressure) 12/2008 - 05/2006
2	COVID-19 09/2022 - 12/2021
2	Immune System Diseases (Immune Disorders) 06/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2016
2	Stroke (Strokes) 01/2019 - 01/2016
2	Metabolic Diseases (Metabolic Disease) 12/2018 - 01/2018
2	Uveal melanoma 02/2018 - 12/2016
2	Schizophrenia (Dementia Praecox) 01/2017 - 08/2012
2	Pathologic Processes 12/2016 - 01/2016
2	Ischemia 04/2015 - 11/2010
1	Heart Failure 09/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2022
1	Pericarditis 09/2022
1	Infections 02/2022
1	Rupture 01/2022
1	Cytokine Release Syndrome 12/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Weight Gain 01/2021

Drug/Important Bio-Agent (IBA)

36	Proteoglycans (Proteoglycan)IBA 01/2022 - 01/2002
24	LipidsIBA 01/2022 - 05/2006
17	GlycosaminoglycansIBA 01/2022 - 05/2002
11	Lipoproteins (Lipoprotein)IBA 11/2020 - 01/2002
10	LDL Lipoproteins (beta Lipoproteins)IBA 06/2020 - 01/2002
7	Pharmaceutical PreparationsIBA 04/2020 - 04/2014
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 05/2006
6	oxidized low density lipoproteinIBA 01/2022 - 01/2002
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2002
5	Phosphotransferases (Kinase)IBA 01/2022 - 08/2008
5	Transcription Factors (Transcription Factor)IBA 12/2021 - 12/2016
5	Biological ProductsIBA 12/2019 - 08/2012
5	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2019 - 12/2010
5	Thrombin FDA Link 01/2019 - 01/2008
5	Insulin (Novolin)FDA Link 02/2018 - 05/2003
5	ApolipoproteinsIBA 01/2016 - 11/2011
4	Endothelin-1 (Endothelin 1)IBA 01/2022 - 07/2008
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2017
4	Peptides (Polypeptides)IBA 06/2019 - 07/2008
4	BiglycanIBA 01/2018 - 10/2008
4	Platelet-Derived Growth FactorIBA 05/2014 - 11/2008
4	tanshinoneIBA 02/2014 - 11/2011
3	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022 - 06/2020
3	CytokinesIBA 12/2021 - 09/2011
3	LigandsIBA 04/2021 - 05/2003
3	PhytochemicalsIBA 01/2021 - 01/2018
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019 - 07/2008
3	Retinaldehyde (Retinal)IBA 01/2018 - 07/2014
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2014 - 08/2012
3	CholesterolIBA 02/2014 - 11/2011
3	ThiazolidinedionesIBA 03/2007 - 05/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 08/2018
2	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2011
2	AntioxidantsIBA 01/2022 - 12/2021
2	low density lipoprotein inhibitorIBA 01/2022 - 06/2010
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2016
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 11/2010
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 08/2012
2	Nerve Growth Factor (NGF)IBA 04/2015 - 01/2014
2	Hormones (Hormone)IBA 05/2013 - 07/2008
2	CollagenIBA 05/2013 - 01/2011
2	Dermatan SulfateIBA 08/2009 - 01/2008
2	ChondroitinIBA 08/2009 - 01/2008
2	PPAR gammaIBA 05/2006 - 05/2003
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2022
1	Colchicine FDA LinkGeneric 09/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 12/2021
1	Tannic Acid FDA Link 12/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2021
1	CurcuminIBA 04/2021
1	Emodin (Archin)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	CanagliflozinIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	empagliflozinIBA 01/2021
1	ferric oxide (iron oxide)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021

Therapy/Procedure

18	Therapeutics 09/2022 - 01/2005
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2021
2	Precision Medicine 07/2019 - 01/2019